A new technique is letting scientists peer into the brain’s wiring with greater detail by simply using a microscope and an LED light, an accessible and cost-effective method that may be useful for studying brain damage in neurological diseases such as multiple sclerosis (MS). The method, called Computational Scattered…
technology
A new wearable brain-mapping tool could dramatically change how doctors monitor people with multiple sclerosis (MS), making it easier to track disease progression and guide personalized care. Researchers showed the system, OPM-MEG, reliably detects abnormalities in the brain’s electrical activity in MS patients. The portable technology is a major…
Researchers have developed a highly sensitive imaging technique that can detect damage to myelin, the fatty wrapping around nerve fibers that is damaged in multiple sclerosis (MS), in large areas of the brain, according to a study. The tool may help assess the extent of myelin damage in…
Life wasn’t just good; it was great. I had the perfect balance of a successful career, a wonderful family, and great friends. After earning an engineering degree and a Master of Business Administration, I launched a rewarding career in the technology industry. I was a leader in my community, was…
A new grant from the Valhalla Foundation will help Octave Bioscience advance the development of a biomarker blood test for detecting disease progression in people with multiple sclerosis (MS). The company is developing its MS Disease Progression test, or MSDP, to objectively measure MS progression based on…
Roxy Murray was living up to being known as “The Multiple Sclerosis Fashionista” when she attended the 2025 European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) conference in Barcelona, Spain, on a warm September afternoon. Murray, who has multiple sclerosis (MS) and lives in London, applies her…
Octave Bioscience has raised $35.6 million in funding to continue marketing its multiple sclerosis (MS) disease activity test and accelerate the development of a similar tool for Parkinson’s disease. The Multiple Sclerosis Disease Activity (MSDA) test — the first blood test of its kind…
A new positron emission tomography (PET) tracer may help determine the extent of nerve fiber loss in multiple sclerosis (MS) lesions, something that can’t be identified with conventional MRI imaging, according to a new study. Researchers think the new imaging tech could help track the efficacy of experimental therapies…
Have you ever been on a flight of stairs and misjudged the height of the steps, causing you to lose your footing? That happens to me more than I’d like to admit. This misjudgment stems from our depth perception, which is our ability to view the world in three dimensions,…
A new imaging technology may help detect early signs of brain damage in people with multiple sclerosis (MS) that aren’t visible on conventional MRI scans, a recent study shows. The technology detects specific metabolic alterations in the brain by tracking certain metabolites and neurotransmitters — molecules that nerve…
Mitochondrial abnormalities, or problems in the powerhouses of cells, seem to be a main contributor to the death of important nerve cells in the cerebellum — a brain region involved in motor control — in people with multiple sclerosis (MS), a new study suggests. Researchers found that inflammation and…
Aetna Healthcare has agreed to reimburse Helius Medical Technologies’ PoNS device, short for Portable Neuromodulation Stimulator, which uses electrical stimulation to improve walking in people with multiple sclerosis (MS). The policy covers PoNS at an out-of-network negotiated price of $18,350, making Aetna, one of the largest private health…
Artificial intelligence (AI)-powered algorithms to analyze data collected on a smartphone app could predict whether a person with multiple sclerosis (MS) will experience certain high-severity symptoms in the next three months, a study shows. The scientists believe this will help empower patients to better understand their disease and…
A particular finding on an MRI scan, called the central vein sign (CVS), is sufficient to support a multiple sclerosis (MS) diagnosis without the need for an invasive lumbar puncture, a new U.K. study suggests. The presence of six lesions with a CVS, where a vein is found…
Octave Bioscience’s Multiple Sclerosis Disease Activity (MSDA) test, which uses data from blood biomarkers to assess multiple sclerosis (MS) disease activity, is now available across all 50 U.S. states to help guide clinicians’ decisions about care. Octave said the test received certification from the New York State Clinical…
A new machine learning tool, a form of artificial intelligence (AI), may accurately detect the transition from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS) — and may be able to do so even earlier than clinicians can — a new study showed. According to the…
Well, it’s that time of year again, and I’m not referring to allergy season or baseball. It’s time for my MRI to evaluate my multiple sclerosis (MS). For the last three years, I was getting an MRI every 18 months. But at my last visit I saw a…
Before I received my relapsing-remitting multiple sclerosis (MS) diagnosis in 2016, I underwent a standard MRI exam, with and without contrast, that scanned my brain, thorax, and cervical spine. I’d never had an MRI before this one. I was vaguely familiar with what the machine looked like, but it’s…
An online training program for managing memory and cognitive difficulties may help people with multiple sclerosis (MS), a study suggests. The program, delivered entirely through virtual sessions, taught participants practical strategies to boost memory then guided them about using the techniques in real-world situations, such as organizing errands, planning…
Biostate AI is partnering with the nonprofit Accelerated Cure Project (ACP) to develop a series of artificial intelligence (AI) models that can predict multiple sclerosis (MS) progression and how patients may respond to treatment. As part of the partnership, Biostate AI will use its high-throughput technology to…
A new artificial intelligence (AI) tool called MindGlide can accurately calculate, from a single MRI scan, multiple aspects of brain damage related to multiple sclerosis (MS) — even when employed with routine scans that are not typically used to monitor such damage. The development and validation of the tool…
Quantum Biopharma is partnering with researchers at Massachusetts General Hospital in Boston on a clinical study to test a positron emission tomography (PET) tracer for monitoring changes in myelin content in people with multiple sclerosis (MS). The Phase 1 study (NCT04699747) is recruiting healthy adults and people…
More Stamina, a gamified mobile app, helped a small group of people with multiple sclerosis (MS) better manage their fatigue by becoming more aware of their energy levels and planning their activities more effectively, according to a study from Finland. “Fatigue is an invisible but life-altering symptom…
Sacral neuromodulation (SNM), in which an implanted device delivers mild electrical pulses to the nerves that control the bladder, led to sustained improvements in urinary function in half of people with multiple sclerosis (MS) who underwent surgery to have the device put into place, according to a review of…
Latifa Janahi takes a five-day course of corticosteroids to reduce inflammation in her body. (Photos courtesy of Latifa Janahi) Day 19 of 31 This is Latifa Janahi’s story: I am a woman from Bahrain Island who’s passionate about technology and baking. After working in the tech field for 10…
The U.S. Food and Drug Administration (FDA) has approved a prefilled syringe format for Ani Pharmaceuticals’ purified Cortrophin Gel that’s expected to reduce the number of steps needed for administering the therapy — used in multiple sclerosis (MS) to treat relapses. The approval means that people with conditions…
I spent most of February staring at a blank screen, the blinking cursor mocking me. Despite having a solid idea to convey and a column deadline looming, my brain was stuck in the mud of cognitive fog. I tried to force my mind to cooperate, but it was like trying…
The Floodlight MS app, a digital health application used to track dexterity, walking function, and cognition in people with multiple sclerosis (MS), has been deemed cost-effective in a new analysis. Modeling simulations showed MS patients who use the app experience fewer relapses and slower disability progression, which would improve…
Nearly all adults with relapsing forms of multiple sclerosis (MS) said they are highly satisfied with the Sensoready autoinjector pen to self-administer Kesimpta (ofatumumab), according to a recent U.S. survey. High satisfaction was mainly driven by the reasonable administration time and ease of use, the researchers said. The…
A new website aims to provide support to caregivers of people with multiple sclerosis (MS). The site, MS Care Partner Connection, brings together information on how caregivers can care for themselves while tending to those living with the disease, how to navigate the healthcare system, and how to…